Bovine lactic acidosis syndrome is associated with large increases of lactic acid in the rumen, which result from diets that are high in ruminally available carbohydrates, or forage that is low in effective fiber, or both. The syndrome involves two separate anatomical areas, the gastrointestinal tract and body fluids, and is related to the rate and extent of lactic acid production, utilization, and absorption. Clinical manifestations range from loss of appetite to death. Lactic acid accumulates in the rumen when the bacteria that synthesize lactic acid outnumber those that utilize lactic acid. The systemic impact of acidosis may have several physiological implications, including laminitis, a diffuse aseptic inflammation of the laminae (corium). Although a nutritional basis for the disease exists, etiology includes a multitude of interactive factors, such as metabolic and digestive disorders, postpartum stress, and localized trauma, which lead to the release of vasoactive substances that trigger mechanisms that cause degenerative changes in the foot. The severity of laminitis is related to the frequency, intensity, and duration of systemic acidotic insults on the mechanisms responsible for the release of vasoactive substance. The critical link between acidosis and laminitis appears to be associated with a persistent hypoperfusion, which results in ischemia in the digit. Management of acidosis is critical in preventing laminitis. High producing dairy herds attempting to maximize energy intake are continually confronted with subclinical acidosis and laminitis. Management of feeding and husbandry practices can be implemented to reduce incidence of disease.
Physical and chemical processing of feed ingredients and feeding management strategies are major instruments of manipulating amount and site of starch digestion in the gastrointestinal tract. Generally, as rumen escape of starch increases, postruminal starch digestion increases, and there does not appear to be a limitation to intestinal starch digestion. However, the efficiency with which postruminal starch is digested decreases, which represents a limitation that warrants investigation. Even though digestible dietary starch is presented to the intestine, there is no net glucose absorption at the portal vein, and plasma glucose levels remain relatively unaffected. This result may be associated with the large metabolic requirement for postruminally absorbed glucose, which is preferentially used for oxidative metabolism at the visceral tissue level. In addition, peripheral glucose concentration is highly regulated. A possible implication is that the exogenous glucose supply may spare endogenously synthesized glucose for gut metabolism, allowing more to be directed to the mammary gland. Amino acids also may be spared (less metabolism of dietary and tissue amino acids in the gut). Current production studies yield no clear evidence as to the benefits of postruminal digestion of starch to enhance milk yield or to change its composition. However, studies suggest that starch digested postruminally is used more efficiently for milk synthesis than that digested in the rumen.
Five hundred seventy-three cows, balanced by parity and 305-d mature equivalent at dry off, were assigned to 1 of 4 treatments: 1) 75% complexed trace minerals (CTM; 75C): Zn, Mn, Cu, and Co supplied at 75% of NRC (2001) guidelines by Zn-, Mn-, and Cu-specific AA complexes, and cobalt glucoheptonate; 2) 100% inorganic (100I): Zn, Mn, Cu, and Co supplied at 100% of NRC (2001) requirements by sulfate sources; 3) 100% complexed (100C): Zn, Mn, Cu, and Co supplied at 100% of NRC (2001) requirements by CTM; and 4) complexed/ inorganic (C/I): Zn and Cu supplied at 100% of NRC (2001) requirements using a combination of CTM and sulfates and Co and Mn supplied with sources at 9.1 and 3.3 times NRC (2001) requirements using a combination of CTM and sulfates. All percentages of Zn, Cu, Mn, and Co relative to NRC (2001) reflect supplemental contributions and do not include basal diet contributions. Experimental periods were dry period 1, full lactation 1, dry period 2, and 200 d into the subsequent lactation. Reproductive, health, and production information was collected during both lactations. Claw evaluations were conducted at trial start, 150 d into lactation 1, at the end of lactation 1, and 150 d into lactation 2. During lactation 1, C/I cows produced more milk, fat-corrected milk, energy-corrected milk, and fat than 100I cows. During lactation 2, yields of milk, fat-corrected milk, energy-corrected milk, fat, and protein were higher for 100C and C/I cows than for 75C or 100I cows. Fat percentage was highest for 100C cows with no treatment effect on protein content. During lactations 1 and 2, C/I cows had fewer days to first estrus than cows receiving the other treatments. During lactation 2, C/ I cows had fewer services per conception and days open. There were no significant effects of treatment on health. White line separation incidence was lower for 100I cows than 75C cows, whereas heel erosion was higher for the 100I cows than for the C/I cows. Fortification of trace elements with inorganic and complexed sources at or above NRC requirements improved reproductive and productive performance. In addition, cows can be supplemented with CTM at 75% of NRC requirements with no reduction in performance compared with supplementing at 100% of NRC requirements using only sulfate sources of Zn, Mn, Cu, and Co.
Effects of supplementing direct-fed microbial agents (DFM) to dairy cows during the transition period were evaluated. Forty-four Holstein cows were fed close-up and lactating diets that did or did not contain 2 g of DFM/cow per d. The direct-fed microbial (DFM) supplement was fed at a rate of 2 × 109 viable yeast cells and 5 × 109 cfu of bacteria per cow per day [corrected].Supplemented cows were fed the DFM 21 d prior to expected calving date through 10 wk postpartum. Cows supplemented with DFM had higher estimated ruminally available dry matter (DM) for both corn silage and haylage than did control cows. Supplemented cows consumed more DM during both the pre- and postpartum periods. In addition, those supplemented with DFM produced 2.3 kg more milk/cow per d than did nonsupplemented cows. There was no difference in 3.5% fat-corrected milk. Milk fat percentage was lower, but not depressed (4.76 vs. 4.44%) for cows receiving DFM. There were no differences in milk fat yield or milk protein percentage and yield. Cows consuming DFM had higher blood glucose postpartum, as well as lower beta-hydroxybutyrate levels both prepartum and on d 1 postpartum. Plasma nonesterified fatty acid concentration was not statistically affected by DFM, but was numerically lower prepartum and higher postpartum for supplemented cows. This study demonstrated that targeted DFM supplementation enhanced ruminal digestion of forage DM. Early lactation cows receiving supplemental DFM produced more milk and consumed more DM during the pre- and postpartum periods. Cows consuming DFM, however, experienced a lower, but not depressed, fat percentage compared with nonsupplemented cows.
Holstein calves (159) were assigned alternately to one of seven regimens through, day 45: nurse dam for 12 to 24 h, dam's milk to 96 h, milk replacer with all milk protein; low (less than or equal to 45 mg/ml) immunoglobulin colostrum to 96 h, then either colostrum, replacer with all milk, or soy protein; high (less than 60 mg/ml) immunoglobulin colostrum to 96 h, then replacer all milk; replacer all milk protein from birth; or saleable milk from birth. Colostrum immunoglobulin was estimated by colostrometer and colostrum was frozen. Starter and water were offered free choice on day 5. Calves deprived of colostrum gained poorly and suffered severe and long scour episodes and high mortality. No differences of body weight gains were observed between calves that nursed compared with those hand fed. Calves fed colostrum with high immunoglobulin gained weight from birth to day 4 while those fed low lost weight. Overall severity and duration of scours were less for calves fed colostrum with high compared to low immunoglobulin. Calves fed undiluted colostrum (5 to 45 days) had more severe scours longer than those fed milk replacer. Serum protein and immunoglobulin were higher for calves hand fed high immunoglobulin compared to low immunoglobulin colostrum or nursing at 12 to 24 h and 4 days after birth. A positive relationship developed between serum protein and immunoglobulin at 12 h to 24 h, 4 and 11 days. Mortality was low for all calves receiving colostrum.
To evaluate the effect of direct-fed microbial (DFM) concentration on diurnal rumen pH profiles and in situ digestibilities, nine ruminally cannulated cows in early lactation were fed treatments consisting of DFM (Enterococcus faecium, Lactobacillus plantarum, and Saccharomyces cerevisiae) at a level of a) 1 x 10(5) cfu/ml of rumen fluid (10(5)), b) 1 x 10(6) cfu/ml of rumen fluid (10(6)), and c) 1 x 10(7) cfu/ml rumen fluid (10(7)). Treatments were directly administered via rumen cannula once daily. Cows were fitted with pH probes in their cannula and connected to dataloggers, which monitor pH hourly. The experimental period was 21 d: 7-d adjustment, 14-d for pH, and in situ measurements. Cows fed 10(5) were able to sustain a higher nadir pH than were cows fed 10(6) or 10(7). Cows fed 10(5) had a higher digestion rate of high moisture ear corn (HMEC) dry matter. Corn silage digestion was higher for cows fed 10(5) and 10(6) compared with those receiving 10(7). There were no carryover effects of treatment associated with rumen pH when switching from one treatment regimen to the next. Results from this study demonstrate that incorporation of a specific level of DFM aids in reducing diurnal ruminal acidity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.